Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST266 in Moderate to Severe Periodontitis
NCT02761993Phase 2Completed
- Sponsor
- Noveome Biotherapeutics
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Cytokines & Interferons, Hormones & Growth Factors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ST266 in periodontitis (3 arms), sponsored by Noveome Biotherapeutics. Primary endpoint: Pocket Depth at 9 months. Started Apr 2016; status: completed.
02
Drugs
ST266
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT02761993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761993.